,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-04-24 02:49:00,Many investors are attracted to consumer staples stocks because these businesses tend to perform well regardless of broader market trends.,0.7201043367385864,0.015401413664221764,0.26449429988861084,positive,0.7047029137611389
1,2017-04-24 02:49:00,"After all, recessions devastate demand for expensive discretionary products like automobiles and homes.",0.06269505620002747,0.458694189786911,0.4786108136177063,neutral,-0.39599913358688354
2,2017-04-24 02:49:00,"But consumers don't easily change their purchasing habits when it comes to their favorite toothpastes, shaving creams, and paper towels.",0.055729612708091736,0.06706800311803818,0.8772023320198059,neutral,-0.011338390409946442
3,2017-04-24 02:49:00,"Below, we'll highlight a few important metrics to watch when evaluating consumer staples stocks and look at why Procter & Gamble (NYSE: PG) , Johnson & Johnson (NYSE: JNJ) , and Colgate-Palmolive (NYSE: CL) deserve a spot on your 2017 watch list.",0.2757585346698761,0.011584145948290825,0.7126573324203491,neutral,0.2641744017601013
4,2017-04-24 02:49:00,"Johnson & Johnson dominates a wide range of markets in the healthcare industry, which makes the blue chip titan a great choice for investors who value diversity.",0.5757211446762085,0.010379250161349773,0.41389957070350647,positive,0.5653418898582458
5,2017-04-24 02:49:00,"Its consumer staples segment is anchored by global brands like Listerine mouthwash, Neutrogena skin care products, and Tylenol painkillers.",0.11530861258506775,0.005138831213116646,0.8795526027679443,neutral,0.11016978323459625
6,2017-04-24 02:49:00,"That portfolio of franchises bounced along at near-zero growth in a weak overall market last quarter, but Johnson & Johnson still managed healthy overall gains thanks to contributions from its other main business lines, medical devices and pharmaceuticals.",0.9491399526596069,0.024464135989546776,0.026395922526717186,positive,0.9246758222579956
7,2017-04-24 02:49:00,"To see why this stock has trounced peers over the long term , investors can simply check its dedication to innovation.",0.4164610505104065,0.019811108708381653,0.563727855682373,neutral,0.39664995670318604
8,2017-04-24 02:49:00,"Backed up by a $9 billion annual research and development budget, Johnson & Johnson directs more resources toward its pipeline of drugs and consumer products than almost any other company could hope to spend.",0.7616668939590454,0.01257391832768917,0.22575917840003967,positive,0.7490929961204529
9,2017-04-24 02:49:00,The healthcare giant expects to boost organic sales by 4% to 5% in 2017 while its earnings grow by as much as 8% to $7.27 per share.,0.9530081152915955,0.018478022888302803,0.02851390466094017,positive,0.9345300793647766
10,2017-04-24 02:49:00,"Toss in a hefty 2.6% dividend yield, and investors should be looking at double-digit total returns this year.",0.6973088979721069,0.023375729098916054,0.27931544184684753,positive,0.6739331483840942
11,2017-04-24 02:49:00,"Procter & Gamble owns many of the biggest consumer brands in the world, including Gillette, which dominates the market for razors and blades with an incredible 65% share.",0.4371389150619507,0.010384331457316875,0.5524767637252808,neutral,0.42675459384918213
12,2017-04-24 02:49:00,Yet that figure is down from 70% just a few years ago as P&G has struggled against rising competition both from cheaper in-store brands and from disruptive business models like Unilever 's online-based Dollar Shave Club.,0.02151423692703247,0.9688748121261597,0.00961106177419424,negative,-0.9473605751991272
13,2017-04-24 02:49:00,"Investors buying the stock today have good reason to expect a brightening overall picture, though, given that P&G has posted two straight quarters of surprisingly strong sales growth paired with improving profitability.",0.9566648006439209,0.020213035866618156,0.023122191429138184,positive,0.93645179271698
14,2017-04-24 02:49:00,"Its new, more targeted product portfolio might be just what the company needs to get back to market-beating sales and earnings gains likely beginning in the back half of 2017 and into 2018.",0.8877657651901245,0.015619238838553429,0.09661494940519333,positive,0.8721465468406677
15,2017-04-24 02:49:00,"In the meantime, shareholders stand to benefit from one of the most generous cash return programs around -- including $22 billion of dividends and stock repurchases this year alone.",0.9233982563018799,0.014533044770359993,0.062068741768598557,positive,0.908865213394165
16,2017-04-24 02:49:00,Some investors may have written Colgate-Palmolive off following a fiscal 2016 that saw revenue decline 5%.,0.017879631370306015,0.970124363899231,0.011996001936495304,negative,-0.952244758605957
17,2017-04-24 02:49:00,"However, look closer and you'll see a business that's as strong as it has ever been.",0.762610137462616,0.01353480201214552,0.22385503351688385,positive,0.7490753531455994
18,2017-04-24 02:49:00,"Organic sales, which strip out currency swings and exited business lines, jumped by 4% last year compared to 2% for Kimberly-Clark and 1% for P&G.",0.9519091248512268,0.03079044818878174,0.017300384119153023,positive,0.9211186766624451
19,2017-04-24 02:49:00,"Colgate also increased its dominant hold on the toothpaste industry, with global market share ticking up to 35.5% from 35.3%.",0.9587429761886597,0.01979643851518631,0.02146049216389656,positive,0.938946545124054
20,2017-04-24 02:49:00,Its U.S. lead rose by the same amount to an incredible 41.4% of the market.,0.9468317031860352,0.020270846784114838,0.03289743512868881,positive,0.9265608787536621
21,2017-04-24 02:49:00,"The most impressive metric in Colgate's arsenal is profitability, though.",0.7238805890083313,0.012570169754326344,0.26354917883872986,positive,0.7113104462623596
22,2017-04-24 02:49:00,"Operating margin is well over 20% of sales to put the company at the top of its industry:

Different characteristics of each of these stocks may appeal to different types of investors.",0.17785918712615967,0.007781431544572115,0.8143594264984131,neutral,0.17007775604724884
23,2017-04-24 02:49:00,"P&G's 3% dividend yield, for example, makes it especially attractive to income investors when compared to Colgate's 2.2% or Johnson & Johnson's 2.6%.",0.7533261775970459,0.02143063023686409,0.2252431958913803,positive,0.7318955659866333
24,2017-04-24 02:49:00,"On the other hand, growth fans would likely prefer Johnson & Johnson thanks to the boost it gets from pharmaceutical hits.",0.33242741227149963,0.018602490425109863,0.6489700675010681,neutral,0.31382492184638977
25,2017-04-24 02:49:00,But all three companies have demonstrated that their businesses can navigate weak industry trends.,0.8427407741546631,0.043066658079624176,0.11419256776571274,positive,0.7996740937232971
26,2017-04-24 02:49:00,"In that way, they exemplify the best of the consumer staples sector: Steady, highly profitable revenue growth that helps fund continued market-share gains and increasing cash returns to investors.",0.9189922213554382,0.013391471467912197,0.06761634349822998,positive,0.9056007266044617
27,2017-04-24 02:49:00,"10 stocks we like better than Procter & Gamble

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12989184260368347,0.022431962192058563,0.8476762175559998,neutral,0.10745988041162491
28,2017-04-24 02:49:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has tripled the market.",0.46925464272499084,0.07301506400108337,0.4577302634716034,positive,0.39623957872390747
29,2017-04-24 02:49:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Procter & Gamble wasn't one of them!",0.18411676585674286,0.01372705027461052,0.8021562099456787,neutral,0.17038971185684204
30,2017-04-24 02:49:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
31,2017-04-24 02:49:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
32,2017-04-24 02:49:00,Demitrios Kalogeropoulos has no position in any stocks mentioned.,0.01237286813557148,0.0730053186416626,0.9146218299865723,neutral,-0.06063245236873627
33,2017-04-24 02:49:00,The Motley Fool owns shares of and recommends Johnson & Johnson.,0.03412320837378502,0.015267993323504925,0.9506087303161621,neutral,0.01885521411895752
34,2017-04-24 02:49:00,The Motley Fool recommends Kimberly-Clark and Unilever.,0.02986503206193447,0.032877299934625626,0.9372576475143433,neutral,-0.0030122678726911545
35,2017-04-24 02:49:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
36,2017-04-24 02:49:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
